Goodwin advised Anthos Therapeutics Inc. on the deal Blackstone Life Sciences and Novartis launched Anthos Therapeutics Inc., a new biopharmaceutical company focused on advancing next generation…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
